Evaluation of treatment of leukoplakia with antioxidant tablets through blood test
Phase 3
- Conditions
- Health Condition 1: Z789- Other specified health status
- Registration Number
- CTRI/2019/01/017358
- Lead Sponsor
- Farheen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Male Subjects aged 18 years and above with (G2 & G3) & without (G1) habit of tobacco consumption (tobacco, chewing with betel quid or tobacco smoking and alcohol consumption)
2.Willing to give written informed consent .
Exclusion Criteria
Alcoholics
2. Known Systemic diseases (coronary heart disease, renal disease, parasitic infections etc) or any malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method